GUAIFENESIN EXTENDE

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of 50 boxes of GUAIFENESIN EXTENDE (NSN 6505017249533) at a unit price of $5.54, resulting in a total contract value of $277.00. The award was issued on July 20, 2026, with delivery required by August 4, 2026, to Fort Stewart, GA, under FOB Destination terms, meaning the contractor bears all freight costs and risks until delivery is completed. Inspection and acceptance occur at the destination, with no deviations permitted in quantity—zero variance tolerance is specified, and medical substitution is allowed under applicable guidelines. The contractor must ship via the fastest traceable means, explicitly prohibiting parcel post, and packages must be marked with the MARKFOR identifier, Traceable Control Number, manufacturer CAGE code, and part number to ensure full DoD supply chain traceability, though no specific MIL-STD packaging or labeling standards are cited. Invoices must be submitted electronically through WAWF in accordance with DFARS 252.232-7003 and are remitted to the Defense Finance and Accounting Service in Columbus, Ohio. Payment office code SL4701 and accounting data BX: 97X4930 5CBX 001 2620 S33189 are provided for financial processing. Contract administration is managed by Lisa Quinn as the Contracting/Ordering Officer and Shairy M. Cartagena as the administrative contact. The NAICS code 424210 identifies the business as a pharmaceutical wholesaler, but no socioeconomic status, size certification, or representational statements are included. No formal contract clauses, special requirements beyond logistics, or evaluation factors are documented, and no attachments or explicit references to standards such as MIL-STD-129 or MIL-STD-2073 are present, suggesting reliance on implied DoD logistics conventions. The underlying contract is inferred as IDIQ, with this delivery order serving as the sole executed task.